NRIX
Price
$25.10
Change
-$0.71 (-2.75%)
Updated
Sep 11 closing price
Capitalization
2.61B
27 days until earnings call
Intraday BUY SELL Signals
REPL
Price
$12.92
Change
-$0.32 (-2.42%)
Updated
Sep 11 closing price
Capitalization
1.22B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs REPL

NRIX vs REPL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRIX vs. REPL commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and REPL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($2.61B) has a higher market cap than REPL($1.22B). REPL (32.922) and NRIX (32.314) have similar YTD gains . REPL has higher annual earnings (EBITDA): -284.22M vs. NRIX (-343.92M). NRIX has more cash in the bank: 444M vs. REPL (195M). NRIX has less debt than REPL: NRIX (58.1M) vs REPL (112M). NRIX has higher revenues than REPL: NRIX (36.8M) vs REPL (0).
NRIXREPLNRIX / REPL
Capitalization2.61B1.22B214%
EBITDA-343.92M-284.22M121%
Gain YTD32.31432.92298%
P/E RatioN/AN/A-
Revenue36.8M0-
Total Cash444M195M228%
Total Debt58.1M112M52%
FUNDAMENTALS RATINGS
NRIX vs REPL: Fundamental Ratings
NRIX
REPL
OUTLOOK RATING
1..100
6960
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9043

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRIX's Valuation (46) in the null industry is in the same range as REPL (54) in the Biotechnology industry. This means that NRIX’s stock grew similarly to REPL’s over the last 12 months.

NRIX's Profit vs Risk Rating (100) in the null industry is in the same range as REPL (100) in the Biotechnology industry. This means that NRIX’s stock grew similarly to REPL’s over the last 12 months.

NRIX's SMR Rating (98) in the null industry is in the same range as REPL (99) in the Biotechnology industry. This means that NRIX’s stock grew similarly to REPL’s over the last 12 months.

NRIX's Price Growth Rating (35) in the null industry is in the same range as REPL (35) in the Biotechnology industry. This means that NRIX’s stock grew similarly to REPL’s over the last 12 months.

NRIX's P/E Growth Rating (100) in the null industry is in the same range as REPL (100) in the Biotechnology industry. This means that NRIX’s stock grew similarly to REPL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRIXREPL
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (NRIX: $25.10 vs. REPL: $12.92)
Brand notoriety: NRIX and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 120% vs. REPL: 83%
Market capitalization -- NRIX: $2.61B vs. REPL: $1.22B
NRIX [@Biotechnology] is valued at $2.61B. REPL’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green while REPL’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while REPL’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • REPL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, REPL is a better buy in the short-term than NRIX.

Price Growth

NRIX (@Biotechnology) experienced а -3.98% price change this week, while REPL (@Biotechnology) price change was -14.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2026.

REPL is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSCC34.830.21
+0.61%
Federated Hermes MDT Small Cap Core ETF
HDEF33.590.10
+0.30%
Xtrackers MSCI EAFE High Div Yld Eq ETF
PFFR17.22N/A
+0.03%
InfraCap REIT Preferred ETF
DVXC23.98N/A
N/A
Webs Defined Volatility Xlc ETF
ONDL5.24-0.05
-0.95%
Defiance Daily Target 2X Long ONDS ETF

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.75%
KYMR - NRIX
57%
Loosely correlated
-1.74%
GPCR - NRIX
45%
Loosely correlated
-2.25%
RCUS - NRIX
45%
Loosely correlated
-5.97%
BCYC - NRIX
45%
Loosely correlated
+0.78%
KURA - NRIX
44%
Loosely correlated
-1.56%
More

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-2.42%
IMNN - REPL
57%
Loosely correlated
+1.38%
SNDX - REPL
49%
Loosely correlated
-3.40%
KYMR - REPL
45%
Loosely correlated
-1.74%
NRIX - REPL
43%
Loosely correlated
-2.75%
ZYME - REPL
42%
Loosely correlated
-0.74%
More